metformin has been researched along with Pemphigoid in 6 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is the first report of drug-induced BP as a group adverse event of the gliptins plus metformin combination therapy for glycaemia control in type 2 diabetes mellitus patients." | 7.78 | Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin. ( Bassukas, ID; Gaitanis, G; Skandalis, K; Spirova, M; Tsartsarakis, A, 2012) |
| "Vildagliptin is a new drug used to treat diabetes mellitus (DM)." | 5.46 | A case of bullous pemphigoid ınduced by vildagliptin. ( Ersoy-Evans, S; Gököz, O; Gönül, M; Keseroglu, HO; Taş-Aygar, G, 2017) |
| " Hypertension, head involvement, and metformin therapy were found to be significantly associated with the need for adjuvant therapy to achieve initial control, suggesting that these parameters may serve as predictors of treatment response in BP." | 3.85 | Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center. ( Geller, S; Kremer, N; Sprecher, E; Zeeli, T, 2017) |
| "This is the first report of drug-induced BP as a group adverse event of the gliptins plus metformin combination therapy for glycaemia control in type 2 diabetes mellitus patients." | 3.78 | Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin. ( Bassukas, ID; Gaitanis, G; Skandalis, K; Spirova, M; Tsartsarakis, A, 2012) |
| "Vildagliptin is a new drug used to treat diabetes mellitus (DM)." | 1.46 | A case of bullous pemphigoid ınduced by vildagliptin. ( Ersoy-Evans, S; Gököz, O; Gönül, M; Keseroglu, HO; Taş-Aygar, G, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kremer, N | 1 |
| Zeeli, T | 1 |
| Sprecher, E | 1 |
| Geller, S | 1 |
| Koga, H | 1 |
| Ishii, N | 1 |
| Ohata, C | 1 |
| Nakama, T | 1 |
| Kridin, K | 1 |
| Bergman, R | 1 |
| Guliani, A | 1 |
| Bishnoi, A | 1 |
| Aggarwal, D | 1 |
| Parsad, D | 1 |
| Keseroglu, HO | 1 |
| Taş-Aygar, G | 1 |
| Gönül, M | 1 |
| Gököz, O | 1 |
| Ersoy-Evans, S | 1 |
| Skandalis, K | 1 |
| Spirova, M | 1 |
| Gaitanis, G | 1 |
| Tsartsarakis, A | 1 |
| Bassukas, ID | 1 |
6 other studies available for metformin and Pemphigoid
| Article | Year |
|---|---|
Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Diabetes Mellitus; | 2017 |
Bullous pemphigoid in a mother (DQB1*03:01:01) and daughter (DRB1*11:01) receiving antidiabetic drugs.
Topics: Aged, 80 and over; Alleles; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; H | 2018 |
Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes: Estimating the Risk of the New Agents and Characterizing the Patients.
Topics: Age Factors; Aged; Aged, 80 and over; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Pe | 2018 |
Teneligliptin-associated bullous pemphigoid in an elderly man with diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Ma | 2018 |
A case of bullous pemphigoid ınduced by vildagliptin.
Topics: Adamantane; Administration, Cutaneous; Clobetasol; Complement C3; Diabetes Mellitus, Type 2; Dipepti | 2017 |
Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin.
Topics: Diabetes Complications; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic | 2012 |